Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Spread of MRSA Linked to Readily Transferred Genetic Element

By LabMedica International staff writers
Posted on 30 Apr 2012
A recent paper demonstrated the key role played by a rare mobile genetic element in the spread of methicillin-resistant Staphylococcus aureus (MRSA).

MRSA is any strain of S. More...
aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins.

In a recent study, investigators at the [US] National Institutes of Health (Bethesda, MD, USA) worked with MRSA clones containing what had been assumed to be an extremely rare mobile genetic element–encoded gene, sasX. However, they reported in the April 22, 2012, online edition of the journal Nature Medicine that after analyzing 807 patient samples from three Chinese hospitals they had found that sasX was more prevalent in MRSA strains from China than previously thought. The gene's frequency was increasing significantly: from 2003 to 2011, the percentage of MRSA samples containing sasX almost doubled, from 21 to 39%.

Experiments conducted with cell cultures and with populations of laboratory mice showed that sasX had a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease, and abscess formation and promoting mechanisms of immune evasion.

The investigators stated that their results vindicated the theory that the emergence of new clones of highly virulent MRSA occurs through horizontal gene transfer, the exchange of DNA between different strains. This was evidenced by observations of transfer of sasX from the ST239 Chinese strain to MRSA clones other than those belonging to this group.

Senior author Dr. Michael Otto, an investigator at the [US] National Institutes of Health, predicted that the frequency of sasX would increase internationally. Plans have been prepared monitor its spread and to develop therapeutics to limit the damage caused by sasX-expressing MRSA strains.

Related Links:

National Institutes of Health



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.